BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12153905)

  • 1. Continuous combined hormone replacement therapy and endometrial hyperplasia.
    Archer DF
    BMJ; 2002 Aug; 325(7358):231-2. PubMed ID: 12153905
    [No Abstract]   [Full Text] [Related]  

  • 2. Continuous combined hormone replacement therapy and risk of endometrial cancer.
    Hill DA; Weiss NS; Beresford SA; Voigt LF; Daling JR; Stanford JL; Self S
    Am J Obstet Gynecol; 2000 Dec; 183(6):1456-61. PubMed ID: 11120510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal bleeding patterns in women receiving hormone replacement therapy. Impact of various progestogen regimens.
    Thorneycroft IH; Gibbons WE
    J Reprod Med; 1999 Feb; 44(2 Suppl):209-14. PubMed ID: 11392034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
    Lethaby A; Farquhar C; Sarkis A; Roberts H; Jepson R; Barlow D
    Cochrane Database Syst Rev; 2000; (2):CD000402. PubMed ID: 10796715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone therapy in postmenopausal women and risk of endometrial hyperplasia: a Cochrane review summary.
    Roberts H; Hickey M; Lethaby A
    Maturitas; 2014 Jan; 77(1):4-6. PubMed ID: 24182544
    [No Abstract]   [Full Text] [Related]  

  • 6. Hormone replacement therapy and endometrial cancer.
    Emons G; Huschmand-Nia A; Krauss T; Hinney B
    Onkologie; 2004 Apr; 27(2):207-10. PubMed ID: 15138357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial cancer and hormone replacement therapy - where does the risk lie?
    Future Oncol; 2005 Jun; 1(3):293. PubMed ID: 16556001
    [No Abstract]   [Full Text] [Related]  

  • 8. [Estrogens and progestins in hormone replacement therapy in menopause].
    La Vecchia C
    Recenti Prog Med; 2001 Mar; 92(3):209-12. PubMed ID: 11320854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial hyperplasia. Risks, recognition and the search for a safe hormone replacement regimen.
    de Lignieres B
    J Reprod Med; 1999 Feb; 44(2 Suppl):191-6. PubMed ID: 11392031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ultrasonic evaluation of endometrial changes induced by cyclic sequential hormone substitution therapy].
    Berardesca C; Chiechi LM; Caradonna F; Loizzi V; Loizzi P
    Minerva Ginecol; 1998 Dec; 50(12):503-5. PubMed ID: 10069161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progestins and coronary heart disease.
    Cano A
    Hum Reprod Update; 1999; 5(3):189-90. PubMed ID: 10438100
    [No Abstract]   [Full Text] [Related]  

  • 12. [Modern tendencies in HRT of patients treated for endometrial cancer].
    Ivanov C
    Akush Ginekol (Sofiia); 2009; 48(2):20-2. PubMed ID: 20198772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal hormone replacement therapy: does the progestin make a difference?
    Fylstra DL
    J S C Med Assoc; 2002 Feb; 98(1):12-9. PubMed ID: 11859600
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of hormone replacement therapy in the management of premature ovarian failure.
    Christin-Maitre S
    Nat Clin Pract Endocrinol Metab; 2008 Feb; 4(2):60-1. PubMed ID: 18030288
    [No Abstract]   [Full Text] [Related]  

  • 15. Patient information. Is hormone replacement therapy for me?
    JAAPA; 2009 Jul; 22(7):58. PubMed ID: 19697574
    [No Abstract]   [Full Text] [Related]  

  • 16. Levonorgestrel intrauterine system for endometrial protection.
    Sturdee D
    J Br Menopause Soc; 2006 Mar; 12 Suppl 1():1-3. PubMed ID: 16513011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of endometrial carcinoma in postmenopause].
    Escudero Fernández M
    Rev Med Univ Navarra; 1993; 38(3):9-12. PubMed ID: 8134756
    [No Abstract]   [Full Text] [Related]  

  • 18. Hormone replacement therapy with estradiol and drospirenone: an overview of the clinical data.
    Whitehead M
    J Br Menopause Soc; 2006 Mar; 12 Suppl 1():4-7. PubMed ID: 16513012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progestogens in estrogen-replacement therapy.
    Gambrell RD
    Clin Obstet Gynecol; 1995 Dec; 38(4):890-901. PubMed ID: 8616984
    [No Abstract]   [Full Text] [Related]  

  • 20. HRT dosing regimens: continuous versus cyclic-pros and cons.
    Shoupe D
    Int J Fertil Womens Med; 2001; 46(1):7-15. PubMed ID: 11294619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.